Financial Information

SEC Filings

AMF Regulated Information

DocumentYearTerms

News • 01/23/2023 | Press releases | Share buyback Programs

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Download PDF

News • 01/04/2023 | Outstanding shares and voting rights statements

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022

Download PDF

News • 12/23/2022 | Press releases

DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial

Download PDF

News • 12/08/2022 | Outstanding shares and voting rights statements

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022

Download PDF

News • 11/03/2022 | Press releases | Quarterly financial information

DBV Technologies Reports Third Quarter Financial Results and Business Update

Download PDF

Annual Reports & General Meetings

DocumentYearTerms

News • 06/09/2022 | Corporate

Amendment to the 2021 URD

Download PDF

News • 06/09/2022 | Corporate | Finance

Securities Note – 2022

Download PDF

News • 05/12/2022 | General Assembly

DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting

Download PDF

News • 04/26/2022 | General Assembly

AGM 2022 – Annual Report

Download PDF

News • 04/26/2022 | General Assembly

AGM 2022 – Definitive Proxy Statement

Download PDF

PFIC Documents